Lv11
34 积分 2020-09-10 加入
FcRn-Hitchhiking BSA-Galactose Nanoparticles for Liver-Targeted Delivery of Astaxanthin in Non-Alcoholic Fatty Liver
3小时前
已完结
Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD
4小时前
已完结
Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
9天前
已完结
皖公网安备34019202002308
